Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.
Saved in:
| Title: | Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. |
|---|---|
| Authors: | Gremke N; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de., Besong I; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Stroh A; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., von Wichert L; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Witt M; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Elmshäuser S; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany., Wanzel M; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Taudte RV; Core Facility for Metabolomics, Philipps University, Marburg, Germany., Schmatloch S; Elisabeth Hospital Kassel, Kassel, Germany., Karn T; UCT Frankfurt-Marburg, Department of Gynecology and Obstetrics, Goethe University, Frankfurt, Germany., Reinisch M; Breast Unit, University Hospital Mannheim, Mannheim, Germany.; Department of Gynecology with Breast Center, University Medicine Berlin, Berlin, Germany., Hirmas N; German Breast Group (GBG), Neu-Isenburg, Germany., Loibl S; German Breast Group (GBG), Neu-Isenburg, Germany., Wündisch T; UCT Frankfurt-Marburg, Comprehensive Cancer Center Marburg, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Litmeyer AS; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Jank P; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Denkert C; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Griewing S; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Wagner U; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany., Stiewe T; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Genomics Core Facility, Philipps-University, Marburg, Germany.; Institute of Lung Health, Justus Liebig University, Gießen, Germany. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 Mar 21; Vol. 10 (1), pp. 92. Date of Electronic Publication: 2025 Mar 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40113784 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gremke+N%22">Gremke N</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de.<br /><searchLink fieldCode="AU" term="%22Besong+I%22">Besong I</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Stroh+A%22">Stroh A</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22von+Wichert+L%22">von Wichert L</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Witt+M%22">Witt M</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Elmshäuser+S%22">Elmshäuser S</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wanzel+M%22">Wanzel M</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Fromm+MF%22">Fromm MF</searchLink>; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Taudte+RV%22">Taudte RV</searchLink>; Core Facility for Metabolomics, Philipps University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmatloch+S%22">Schmatloch S</searchLink>; Elisabeth Hospital Kassel, Kassel, Germany.<br /><searchLink fieldCode="AU" term="%22Karn+T%22">Karn T</searchLink>; UCT Frankfurt-Marburg, Department of Gynecology and Obstetrics, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Reinisch+M%22">Reinisch M</searchLink>; Breast Unit, University Hospital Mannheim, Mannheim, Germany.; Department of Gynecology with Breast Center, University Medicine Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hirmas+N%22">Hirmas N</searchLink>; German Breast Group (GBG), Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; German Breast Group (GBG), Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wündisch+T%22">Wündisch T</searchLink>; UCT Frankfurt-Marburg, Comprehensive Cancer Center Marburg, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Litmeyer+AS%22">Litmeyer AS</searchLink>; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Jank+P%22">Jank P</searchLink>; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Denkert+C%22">Denkert C</searchLink>; Institute of Pathology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Griewing+S%22">Griewing S</searchLink>; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wagner+U%22">Wagner U</searchLink>; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Gießen and Marburg Campus Marburg, Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Stiewe+T%22">Stiewe T</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Genomics Core Facility, Philipps-University, Marburg, Germany.; Institute of Lung Health, Justus Liebig University, Gießen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2025 Mar 21; Vol. 10 (1), pp. 92. <i>Date of Electronic Publication: </i>2025 Mar 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40113784 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-025-02180-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 92 Titles: – TitleFull: Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gremke N – PersonEntity: Name: NameFull: Besong I – PersonEntity: Name: NameFull: Stroh A – PersonEntity: Name: NameFull: von Wichert L – PersonEntity: Name: NameFull: Witt M – PersonEntity: Name: NameFull: Elmshäuser S – PersonEntity: Name: NameFull: Wanzel M – PersonEntity: Name: NameFull: Fromm MF – PersonEntity: Name: NameFull: Taudte RV – PersonEntity: Name: NameFull: Schmatloch S – PersonEntity: Name: NameFull: Karn T – PersonEntity: Name: NameFull: Reinisch M – PersonEntity: Name: NameFull: Hirmas N – PersonEntity: Name: NameFull: Loibl S – PersonEntity: Name: NameFull: Wündisch T – PersonEntity: Name: NameFull: Litmeyer AS – PersonEntity: Name: NameFull: Jank P – PersonEntity: Name: NameFull: Denkert C – PersonEntity: Name: NameFull: Griewing S – PersonEntity: Name: NameFull: Wagner U – PersonEntity: Name: NameFull: Stiewe T IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 03 Text: 2025 Mar 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2059-3635 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Signal transduction and targeted therapy Type: main |
| ResultId | 1 |